Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Spe
![RedgedapS: Guía para la prevención de la diabetes tipo 2 y de los eventos cardiovasculares en pacientes con síndrome metabólico RedgedapS: Guía para la prevención de la diabetes tipo 2 y de los eventos cardiovasculares en pacientes con síndrome metabólico](https://1.bp.blogspot.com/-Xoop16xqv0Q/XWJoVAtXP_I/AAAAAAAATCQ/KRIVIm3JytMM1A7ev9kDkuRB9Yi0_97WACLcBGAs/s1600/2019-08-23-GPC-SM-DM-y-ECV.jpg)
RedgedapS: Guía para la prevención de la diabetes tipo 2 y de los eventos cardiovasculares en pacientes con síndrome metabólico
![Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study - The Lancet Digital Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study - The Lancet Digital](https://www.thelancet.com/cms/asset/4cbf4e75-2bca-4dd4-9d1c-db4f7fbc6cc8/gr1.jpg)
Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: an in silico cohort study - The Lancet Digital
![Cardiovascular Risk Assessment in the Older Athlete - Alec J. Moorman, Larry S. Dean, Eugene Yang, Jonathan A. Drezner, 2021 Cardiovascular Risk Assessment in the Older Athlete - Alec J. Moorman, Larry S. Dean, Eugene Yang, Jonathan A. Drezner, 2021](https://journals.sagepub.com/cms/10.1177/19417381211004877/asset/images/large/10.1177_19417381211004877-fig1.jpeg)